Stoke Therapeutics (STOK) News Today $12.31 -0.91 (-6.88%) Closing price 04:00 PM EasternExtended Trading$12.31 0.00 (0.00%) As of 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock STOK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Stoke Therapeutics (NASDAQ:STOK) Trading Down 4.3% - Here's Why5 hours ago | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Earns Buy Rating from Analysts at Jefferies Financial GroupJuly 20 at 3:21 AM | americanbankingnews.comJefferies Initiates Coverage of Stoke Therapeutics (STOK) with Buy RecommendationJuly 19 at 2:19 AM | msn.comJefferies starts Stoke at Buy, sees $1 bln+ opportunity in rare epilepsy drugJuly 19 at 2:19 AM | finance.yahoo.comStoke Therapeutics (NASDAQ:STOK) Shares Gap Up - What's Next?July 18 at 12:03 PM | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Now Covered by Analysts at Jefferies Financial GroupJuly 18 at 9:31 AM | marketbeat.comEpilepsy Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightJuly 15, 2025 | theglobeandmail.comStoke Therapeutics (NASDAQ:STOK) investors are sitting on a loss of 58% if they invested five years agoJuly 15, 2025 | finance.yahoo.comThe charming Stoke-on-Trent four-bed family home that's 'ready to be lived in'July 13, 2025 | msn.comNew Royal Stoke technology cuts hospital stays by over a dayJuly 13, 2025 | msn.comGrit bin raiders and double parking hinders work to keep Stoke-on-Trent moving in winterJuly 13, 2025 | msn.comFive of the best beer gardens around Stoke-on-Trent to enjoy in the sunJuly 13, 2025 | msn.comMan City prospect told to gain notoriety at Stoke CityJuly 13, 2025 | msn.comLille rival Aston Villa in race for Stoke’s Sol SidibéJuly 10, 2025 | sports.yahoo.comAston Villa want Stoke City midfielder Sol SidibeJuly 10, 2025 | sports.yahoo.comCouncil still against Stoke-on-Trent 'merger' as devolution decision gets nearerJuly 10, 2025 | msn.comStoke City close in on fourth summer signingJuly 10, 2025 | msn.comStoke Therapeutics and Biogen Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) CongressJuly 10, 2025 | businesswire.comBiogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) CongressJuly 10, 2025 | globenewswire.comPolice helicopter tracks 4 masked kids on stolen motorbikes in Stoke-on-Trent parkJuly 8, 2025 | msn.comStoke-on-Trent firm collapses into administrationJuly 8, 2025 | msn.comDriver dies in Royal Stoke after hitting treeJuly 8, 2025 | msn.comStoke City move early for 'lethal' rising Manchester City star in second signing of the dayJuly 7, 2025 | msn.comNew Hanford waste incinerator could keep patients warm at Royal StokeJuly 7, 2025 | msn.comStoke sign Talovierov and Man City's MubamaJuly 7, 2025 | msn.comZebra crossings to be installed outside TWO schools on same Stoke-on-Trent roadJuly 5, 2025 | msn.comStoke-on-Trent-based Prohire Limited falls into administrationJuly 5, 2025 | bbc.co.ukMaksym Talovierov makes 'cold nights' promise with brilliant Stoke City statementJuly 5, 2025 | msn.comFive Guys to open first Stoke-on-Trent restaurantJuly 5, 2025 | msn.comMubama set for Stoke loan switchJuly 5, 2025 | sports.yahoo.comPorch pirates target Stoke-on-Trent as parcels swiped from doorstepsJuly 3, 2025 | uk.news.yahoo.comStoke City on brink of agreement for Plymouth Argyle record signingJuly 2, 2025 | msn.comStockley named Stoke's new academy managerJuly 2, 2025 | msn.comStoke Therapeutics' (STOK) "Buy" Rating Reaffirmed at Needham & Company LLCJuly 1, 2025 | marketbeat.comStoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Rating of "Buy" from AnalystsJune 30, 2025 | marketbeat.comSTOK Stoke Therapeutics, Inc. - Seeking AlphaJune 29, 2025 | seekingalpha.comAnalysts Are Bullish on These Healthcare Stocks: Apogee Therapeutics (APGE), Legend Biotech (LEGN)June 28, 2025 | theglobeandmail.comStoke-on-Trent bungalow could be turned into children's homeJune 28, 2025 | msn.comStoke City confirm new coach appointment as pre-season startsJune 27, 2025 | msn.comStoke Therapeutics (NASDAQ:STOK) Trading Down 3.5% - Here's WhyJune 26, 2025 | marketbeat.comStoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 17, 2025 | businesswire.comSTOK FY2025 EPS Forecast Lowered by Cantor FitzgeraldJune 16, 2025 | marketbeat.comStoke Therapeutics: Impressive Pipeline And Big BackersJune 15, 2025 | seekingalpha.comAssenagon Asset Management S.A. Sells 391,322 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK)June 15, 2025 | marketbeat.comCantor Fitzgerald Predicts STOK FY2026 EarningsJune 10, 2025 | marketbeat.comKangaroo Care Awareness Day celebrated at Stoke Mandeville HospitalJune 10, 2025 | msn.comJong Oranje and Stoke City star is open to transfer: “Of course, I have my ambitions”June 10, 2025 | sports.yahoo.comStoke City confirm next stage of major badge consultationJune 10, 2025 | msn.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK)June 10, 2025 | marketbeat.comStoke Therapeutics, Inc. (NASDAQ:STOK) Shares Sold by Two Sigma Investments LPJune 9, 2025 | marketbeat.com Get Stoke Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for STOK and its competitors with MarketBeat's FREE daily newsletter. Email Address STOK Media Mentions By Week STOK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STOK News Sentiment▼0.440.61▲Average Medical News Sentiment STOK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STOK Articles This Week▼95▲STOK Articles Average Week Get Stoke Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for STOK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARWR News IBRX News OGN News APLS News XENE News NAMS News BHC News AGIO News TWST News INDV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:STOK) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stoke Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stoke Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STOK Stock Alerts